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Using indirect immunofluorescence assays on frozen tissue 
sections of skin from healthy subjects and subjects with in- 
flammatory skin diseases, we found that intercellular adhe- 
sion molecule-l (ICAM-1) was expressed in a cell surface 
pattern on epidermal keratinocytes at the site of lymphoid 
infiltration in cutaneous dermatoses. ICAM- was not ex- 
pressed on epidermal keratinocytes in noninflamed skin. Its 
expression was not related solely to epidermal hyperprolif- 
eration, as hyperproliferative, tape-stripped epidermis did 
not express ICAM-1. We have reported previously that 
ICAM- expression on epidermal keratinocytes was upregu- 
lated by treatment with interferon gamma and that activated 
T lymphocytes bound to cultured epidermal keratinocytes in 
vitro by lymphocyte function associated-l (LFA-1) mole- 
cules on T cells and ICAM- on epidermal keratinocytes. 
Taken together, these data suggest that upregulation of ex- 
pression of ICAM- is an im ortant feature of cutaneous 
inflammation.] Invest Dermato 92:746- 750, 1989 P 
I nfiltration of the skin by activated T lymphocytes is charac- teristic of many inflammatory dermatoses [I]. In some of these cutaneous dermatoses (i.e., graft versus host disease, allergic contact dermatitis, lichen planus), the infiltration of activated T lymphocytes into the skin is accompanied by 
expression on epidermal keratinocytes (EK) of major histocompati- 
bility complex (MHC) class II molecules [2- 111, which in normal 
epidermis is limited to Langerhans cells [12- 141 and acrosyringial 
epithelial cells [I5]. M . ajar h’ t 1s ocompatibility complex class II mol- 
ecules can be induced in vitro on EK by interferon gamma (IFN-y), a 
cytokine produced by activated T lymphocytes [16]. These data 
have led to the suggestion that activated T lymphocytes migrating 
to the epidermis may induce expression of MHC class II molecules 
on the surface of EK by produceing IFN-y. The functional conse- 
quences in vivo of MHC class II expression by EK are not known. 
Gaspari and Katz [17] reported that MHC class II-positive murine 
EK can present antigenic peptides to T cell hybridomas and serve as 
targets for MHC class II restricted cytolytic T cell clones, suggest- 
ing that MHC class II-positive keratinocytes can partici ate in some 
immune reactions. In addition, Gaspari and colleagues P 181 recently 
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reported that in some instances MHC class II-positive murine EK 
may play a role in suppressing immune responses. 
Another molecule whose expression can be regulated by IFN-y is 
intercellular adhesion molecule-l (ICAM-1) [19,20]. ICAM-I is a 
cell surface glycoprotein of relative molecular mass 90,000- 
100,000 that can serve as one ligand for the lymphocyte adhesion 
molecule LFA- 1 in lymphocyte interactions with a variety of differ- 
ent cell types [21- 261. We have previously reported that activated 
T lymphocytes bound to EK that had been treated with IFN-y [22], 
but bound only minimally to EK that were not treated with IFN-7. 
Lymphocyte binding to IFN-y-treated EK was completely abro- 
gated by antibodies to LFA-1 and to ICAM-1, suggesting that 
ICAM-l/LFA-1 interactions were critical for interactions between 
activated human T lymphocytes and IFN-y-treated EK. 
If LFA-l/ICAM-1 interactions are important in vivo in inflam- 
matory dermatoses, then ICAM-I should be expressed on the sur- 
face of EK during cutaneous inflammation. In this study, we report 
that although ICAM-I was not expressed on normal epidermis, 
ICAM-I was focally expressed on EK in a cell surface pattern in a 
variety of inflammatory dermatoses. The upregulation of ICAM-I 
expression was not the result of hyperproliferation of the epidermis, 
as mechanical induction of hyperproliferation by tape stripping [27] 
did not induce epidermal expression of ICAM-I. Thus, modulation 
of the expression of ICAM- by EK may be important in the patho- 
genesis of cutaneous inflammation. 
MATERIALS AND METHODS 
Tissue Specimens Three-millimeter punch biopsies were ob- 
tained after informed consent from patients or from healthy volun- 
teers. The patients’ diagnoses were established by clinical criteria 
and routine histopathology of the biopsies. We examined biopsies 
from 5 patients with atopic dermatitis, 2 patients with graft-versus- 
host disease, 2 patients with psoriasis, 2 patients with lichen simplex 
chronicus, and 5 patients with spongiotic dermatitis including 2 
with contact dermatitis and 3 with spongiotic dermatitis of un- 
known etiology. We also examined biopsies of 6 patients with 
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cutaneous T cell lymphoma. Each biopsy was snap frozen, mounted pathologic skin conditions involving epidermal hyperproliferation 
in O.C.T. 4583 embedding compound (Miles Laboratories, Elk- and in mechanically tape-stripped skin, the pattern of reactivity of 
hart, IN), cut into 4-,um sections using an A0 Histostat Microtome AEl changes within 24 h to a suprabasal pattern [29]. In most of the 
(Reichert-Jung, Buffalo, NY), and processed for immunofluores- biopsies we studied, AEl stained in a pattern consistent with hyper- 
cence. In each case, sample cryostat sections were stained with he- 
matoxylin and eosin. To induce epidermal hyperproliferation for 
proliferation of the epidermis (Fig 2.D). To examine ICAM- ex- 
pression on hyperproliferative epidermis in the absence of a lymph- 
control experiments, skin of the inner, upper arm of two volunteers oid infiltrate, we examined biopsies of skin that had been 
was stripped using Scotch brand tape, type 810 (3M, St. Paul, MN), mechanically tape stripped and shown to express a pattern of reac- 
until the skin glistened (approximately 50 times). Biopsies were tivity with AEl consistent with that seen in hyperproliferative epi- 
taken 48 h later 1281. dermis. Frozen sections were evaluated for exnression of ICAM- 
L 1 
Indirect Immunofluorescence Indirect immunofluorescence 
was performed on cryostat-sectioned tissues as previously described 
[29]. In some cases, immunofluorescence was performed on consec- 
utive sections with specific monoclonal reagents. The following 
dilutions of monoclonal antibodies were used: 1:lOOO AEl (anti- 
keratin) [30], 1:lOOO RRl/l (anti-ICAM-1) [20], 1:500 L243, 
which reacts with a non 
(HLA-DR) molecules [31 , 1:500 TS1/22 (anti-LFA-1) [32], and P 
olymorphic epitope of MHC class II 
I:500 Leu4, which reacts with the epsilon chain of the CD3 mole- 
cule associated with the T cell antigen receptor [33]. 
RESULTS 
Expression of Intercellular Adhesion Molecule-l on Tissue 
Sections of Inflamed Skin Normal human skin from several 
body sites including upper arm, foreskin, and breast was examined 
for expression of ICAM-1. As shown in Fig lA, ICAM- expression 
was not detected within the epidermis. Although it is not readily 
seen in Fig lA, vascular endothelium did express ICAM-1. In con- 
trast, in a variety of cutaneous dermatoses, EK expressed ICAM- in 
a cell surface pattern (Fig 1 B-D). Intercellular adhesion molecule- 
1 expression was detected on EK in lesional skin of atopic dermatitis 
(3 of 5 patients), allergic contact dermatitis (2 of 2 patients), spon- 
giotic dermatitis of unknown etiology (2 of 3 patients), lichen sim- 
plex chronicus (2 of 2 patients), psoriasis (2 of 2 patients), graft- 
versus-host disease (2 of 2 patients), and cutaneous T cell lymphoma 
(5 of 6 patients). In addition, vascular endothelium was strongly 
reactive with antibody to ICAM-1, as was the dermal mononuclear 
cell infiltrate (Fig lB,D). 
on EK. Tissue sections were also evaluated with antibodies to CD3 
and LFA-1 to confirm that tape stripping did not induce lymphoid 
infiltration of the skin. Figure 2.D shows the pattern of reactivity 
expected for AEl on hyperproliferative epidermis from a patient 
with spongiotic dermatitis. Tape-stripped epidermis showed a simi- 
lar pattern of reactivity with AEl (Fig 2E) but was not reactive with 
antibody to ICAM- (Fig 2F). Thus, tape stripping clearly induced 
changes in keratin expression associated with hyperproliferation of 
epidermis but did not induce ICAM- expression on EK. No HLA- 
DR expression was detected on EK In tape-stripped epidermis (not 
shown). Companion sections reacted with antibodies to lymphoid 
cells confirmed that tape stripping did not induce lymphoid infiltra- 
tion (not shown). 
DISCUSSION 
In this study, we report that ICAM- was expressed in a cell-surface 
pattern on EK at the site of lymphoid infiltration in cutaneous 
dermatoses. Furthermore, ICAM- expression was not associated 
with epidermal hyperproliferation in the absence of lymphoid i&l- 
tration. It is likely that ICAM- expression is related to infiltration 
of activated lymphocytes into the skin. 
Adhesion of T lymphocytes to hematopoietic and nonhemato- 
poietic cells is required for induction and maintenance of immune 
responses. In recent years, attention has been focused on the role of 
molecules, other than the B and T cell receptor for antigen, in 
mediating adhesion of lymphoid cells [reviewed in Ref 361. The 
CD4 and CD8 molecules have been implicated in direct interaction 
with MHC class II and class I products, respectively [37]. In addi- 
tion, two pairs of molecules have been implicated as serving impor- 
tant roles in lymphoid adhesion. The CD2 interaction with its 
ligand LFA-3 is involved in cytotoxic T lymphocyte binding to 
target cells [38] and in thymocyte binding to thymic epithelial cells 
[39]. The importance of these two molecules goes beyond their role 
in binding, as recent reports have demonstrated that, in appropriate 
combination with other signals, purified LFA-3 molecules can de- 
liver activation signals to thymocytes [40] and to T cells [41,42] by 
CD2 molecules. The adhesion molecule LFA-1 is expressed on 
hematopoietic cells and has been shown to articipate in a variety of 
T and B cell functions as well as myeloid unctions [25,42-451. A P 
clinical syndrome has been described in which a heritable deficiency 
of LFA-1 and two other molecules, which share a common beta 
chain, Mac-l and 
P 
150,95, result in a deficiency of cellular inflam- 
matory responses 461. 
Expression of ICAM- by EK was frequently focal in nature and 
correlated well with the extent of inflammation (Fig 2A). When 
sequential sections were evaluated for expression of ICAM-1, CD3, 
and LFA-1, the expression of ICAM- on EK correlated well with 
the presence of a CD3-positive infiltrate. CD3-positive cells were 
seen in the perivascular, superficial dermis and frequently within 
the epidermis as well as (Fig 2B). The T cell infiltrate was also 
reactive with antibody TS1/22 (anti-LFA-1) (Fig 2C’). Cells reac- 
tive with anti-LFA-1 but not anti-CD3 were also detected. The 
sections shown in Fig 2/I-C were from a patient with atopic der- 
matitis. In agreement with previous reports [34,35], we found that 
lesions of acute atopic dermatitis were characterized by a mononu- 
clear infiltrate of primarily lymphocytes with CD4+ cells predomi- 
nating. As reported by Zachary et al [35], infiltrating T cells ex- 
pressed HLA-DR antigens as detected by L243 (not shown), and 
thus are activated. Ex 
seen in focal areas o 4 
ression of both ICAM- and HLA-DR was 
inflammation. Although typically EK that 
expressed ICAM- also expressed HLA-DR, one exception was a 
case of spongiotic dermatitis in which ICAM- expression was de- 
tected in a cell surface pattern on EK located near a focal infiltration 
of CDS-positive cells, however, no HLA-DR expression by epider- 
ma1 keratinocytes was observed. 
Intercellular Adhesion Molecule-l Expression by Epidermal 
Keratinocytes Not a Result of Hyperproliferation Because 
most of the diseases in which we detected EK ICAM- expression 
also involved hyperproliferation of the epidermis, we considered 
the possibility that the expression of ICAM- was a result of epider- 
ma1 hyperproliferation. Epidermal hyperproliferation is accompa- 
nied by an alteration in expression of keratin polypeptides that can 
be monitored using the antikeratin antibody AEl. In healthy skin, 
AEl binds primarily to the basal layer of epidermis [31], whereas in 
Although other LFA-1 ligands probably exist, ICAM- has been 
shown to function as a ligand for LFA-1 in binding of T lympho- 
cytes to endothelial cells [24], target cells for cytotoxic T lympho- 
cytes [26], and in binding of activated T lymphocytes to IFN-y- 
treated EK [22] and to IFN-y-treated thymic epithelial cells [Singer 
KH, Tuck DT, Smith J, Haynes BF, unpublished results). The gene 
for ICAM- has recently been sequenced [47,48] and demonstrated 
to share homology with members of the immunoglobulin gene 
superfamily, whereas LFA-1 has been shown to have structural ho- 
mology with the integrin family of adhesion molecules [49]. Thus, 
the interaction of LFA-1 and ICAM- is an interaction between a 
member of the integrin family of molecules, LFA-1, and a member 
of the immunoglobulin family of molecules, ICAM- 1. 
The presence of lymphocytes within the epidermis is a frequent 
feature of many inflammatory dermatoses; however, the mecha- 
nism of exocytosis is not known. The expression of adhesion mole- 
cules on the surface of EK provides a mechanism for binding of 
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Reactivity of antibodies to (A) ICAM- 1, (B) CD3, and (C) LFA-1 with consecutive cryostat sections of skin from a patient with atopic dernx 
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activated T lymphocytes to epidermal cells at the site of cutaneous 
inflammation. The functional consequence of the interaction of 
activated T lymphocytes with EK is currently under investigation. 
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